Valeant to Buy Dermik Division From Sanofi

Canadian drugmaker Valeant Pharmaceuticals said it is buying Dermik, a skin-treatment division of France’s Sanofi, for about $425 million in cash. Dermik makes such products as acne treatment BenzaClin and Sculptra, an injectable solution for smoothing out wrinkles.
The Vancouver Sun